The FDA officially approved Ocrelizumab (brand name: Ocrevus) for use in multiple sclerosis treatment on March 28, 2017. In this live Q&A, Dr. Enrique Alvarez answers some common questions on…
We are always working to bring you educational resources about MS to help inform you about both the disease itself and about living with MS. The Rocky Mountain MS Center is pleased to bring you a series of webinars on topics that you’ve told us you would like to learn more about.